NCT06944470 2025-04-25JS207 Combined With Chemotherapy in Subjects With Stage II-III NSCLCShanghai Junshi Bioscience Co., Ltd.Phase 2 Not yet recruiting76 enrolled
NCT06746870 2024-12-24A Phase II Clinical Study to Evaluate the Safety, Pharmacokinetic Profile, and Preliminary Efficacy of IMM2510 in Combination with Chemotherapy As First-line Treatment in Subjects with Non-small Cell Lung Cancer or Triple-negative Breast CancerImmuneOnco Biopharmaceuticals (Shanghai) Inc.Phase 2 Not yet recruiting148 enrolled